Brown, Lisle/Cummings, Inc. Becton Dickinson & CO Transaction History
Brown, Lisle/Cummings, Inc.
- $307 Billion
- Q2 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 798 shares of BDX stock, worth $184,130. This represents 0.06% of its overall portfolio holdings.
Number of Shares
798
Previous 798
-0.0%
Holding current value
$184,130
Previous $197 Million
5.55%
% of portfolio
0.06%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding BDX
# of Institutions
1,726Shares Held
241MCall Options Held
638KPut Options Held
759K-
Vanguard Group Inc Valley Forge, PA26.2MShares$6.04 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$5.26 Billion0.13% of portfolio
-
State Street Corp Boston, MA13.5MShares$3.12 Billion0.15% of portfolio
-
Morgan Stanley New York, NY10.7MShares$2.47 Billion0.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.1MShares$2.34 Billion0.31% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $65.8B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...